Gut microbiota on the obese and cardiovascular risk patient
DOI:
https://doi.org/10.47196/diab.v56i3Sup.538Keywords:
microbiota, cardiovascularAbstract
Obesity is a disease that has multiple causes and a complex etiology. Lately, the percentage of the population that become obese has been increasing, affecting everyone, regardless of the patient’s age. Furthermore, obesity may lead to other diseases like diabetes type II or cardiovascular diseases.
One of the recent discoveries about this topic is the relation between the microorganisms that make up the gut microbiota and obesity2.
References
I. Ching-Hung T, Chun-Ying W. The gut microbiome in obesity. J of the Formosan Medical Association 2019;118:53-59.
II. Scheithauer TPM, Rampanelli E, Nieuwdorp M, Vallance B, et al. Gut microbiota as a trigger for metabolic inflamation in obesity and type 2 diabetes. Frontiers in Inmunology 2020;11:571-731.
III. Asadi A, Shadab Mehr N, Mohamadi MH, Shokri F, et al. Obesity and gut-microbiota brain axis: a narrative review. J Clin Anal 2022;36 e24420.
IV. Gawalko M, Agbaedeng TA, Saljic A, Muller DM, et al. Gut microbiota, dysbiosis and atrial fibrillation. Arrhythmogenic mechanism and potencial clinical implications. Cardiovasc Res 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
